ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.23
      0.77%
      US Tech 100
      19,435.60
      0.17%
      Dow Jones
      38,778.10
      0.49%
      Brent Oil
      83.72
      -0.21%
      Bitcoin
      65,292.13
      -1.80%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inhibrx Biosciences Inc (INBX)

      7. Inhibrx Biosciences Inc (INBX) News

      INBX Inhibrx Biosciences Inc

      14.19
      0.00 (0.00%)
      Pre Market
      Last Updated: 07:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Inhibrx Biosciences Inc INBX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 14.19 07:00:00
      Open Price Low Price High Price Close Price Prev Close
      14.19
      more quote information »

      Recent News

      Date Time Source Heading
      5/31/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/30/202418:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/30/202416:34EDGAR2Form S-8 POS - Securities to be offered to employees in..
      5/30/202416:32EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
      5/30/202416:13EDGAR2Form 8-K - Current report
      5/28/202416:55EDGAR2Form 144 - Report of proposed sale of securities
      5/24/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/24/202416:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
      5/24/202416:08EDGAR2Form 8-K - Current report
      5/24/202416:00PRNUSInhibrx Inc. Stockholders Approve Sale of INBRX-101 to..
      5/22/202409:54EDGAR2Form 144 - Report of proposed sale of securities
      5/20/202421:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      5/17/202417:29EDGAR2Form 8-K - Current report
      5/17/202416:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      5/10/202418:36PRNUSInhibrx, Inc. Announces Updated When-Issued Trading Date for..
      5/09/202416:08EDGAR2Form 8-K - Current report
      5/08/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/08/202416:42EDGAR2Form 8-K - Current report
      5/08/202416:37PRNUSInhibrx, Inc. Announces Record Date and Expected..
      5/06/202417:16EDGAR2Form 144 - Report of proposed sale of securities
      3/11/202416:26EDGAR2Form 144 - Report of proposed sale of securities
      3/08/202416:08EDGAR2Form 144 - Report of proposed sale of securities
      3/08/202415:28EDGAR2Form 144 - Report of proposed sale of securities
      3/06/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202414:58EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202418:26EDGAR2Form 144 - Report of proposed sale of securities
      2/29/202417:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
      2/28/202409:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
      2/28/202409:12EDGAR2Form 8-K - Current report
      2/28/202409:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/14/202416:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/06/202416:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      1/26/202412:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
      1/23/202417:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      1/23/202406:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      1/23/202406:35EDGAR2Form 8-K - Current report
      1/23/202406:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
      1/23/202405:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
      1/23/202401:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
      11/09/202316:03EDGAR2Form 8-K - Current report
      11/09/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/09/202316:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
      11/02/202309:16EDGAR2Form 8-K - Current report
      11/02/202309:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
      10/18/202316:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
      9/19/202316:03EDGAR2Form 8-K - Current report
      9/19/202316:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
      8/29/202309:03EDGAR2Form 8-K - Current report
      8/29/202309:00PRNUSInhibrx Announces $200 Million Private Placement Financing
      8/07/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      Your Recent History

      NASDAQ
      INBX
      Inhibrx Biosciences
      BIT
      OATL5
      SG ETN Daily Short5X Oat...
      BTRX
      CLOAKBTC
      EU
      WFIN
      Spdr Msci World Financia...
      NASDAQ
      AFYA
      Afya
      LSE
      3LBC
      Granite 3xl Bar
      LSE
      GQ22
      Gov.hk.28 (a)
      NASDAQI
      CX65PI
      OMX Copenhagen Utilities...
      LSE
      83HC
      Tesco 5.125%
      TG
      M1I
      MGP Ingredients
      ASX
      DRUG
      BetaShares Capital
      LSE
      66XL
      Khadrawy 25 S
      Delayed Upgrade Clock